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1. Introduction   
In a normal cell, there exists a balance between the free radical generation and the 
antioxidant defense (Devi et al., 2000). It has long been documented that cancer cells are 
under increased and persistent oxidative stress due to increased reactive oxygen species. 
Oxidative stress describes the state of a cell whose antioxidant mechanisms can not manage 
its content of free radicals (Figure 1). As a consequence, cellular constituents are disrupted, 
and free radical reactions become less controllable since endogenous antioxidants are 
themselves injured by oxidative insults. Oxidative stress induces a cellular redox imbalance 
which has been found to be present in various cancer cells compared with normal cells; the 
redox imbalance thus may be related to oncogenic stimulation (Valko et al., 2006). Increased 
intrinsic reactive oxygen species (ROS) stress in cancer cells has been speculated to be due to 
a number of factors such as oncogenic stimulation, increased metabolic activity, and 
mitochondrial malfunction (Pelicano et al., 2004).The cellular redox state has important 
effects on the control of cell survival, apoptosis, and expression of tumor suppressor genes. 
A high cell redox state would encourage tumor formation by creating an enhanced cell 
proliferative environment. In opposition to this, a high cell redox state would also support 
increased apoptosis, which would inhibit tumor formation by eliminating partially 
transformed cells. In addition to ROS, various redox metals, due to their ability to generate 
free radicals, or non-redox metals, due to their ability to bind to critical thiols, have been 
implicated in the mechanisms of carcinogenesis. (Leonard et al., 2004; Valko et al., 2005). 
Cancer cells can generate large amounts of hydrogen peroxide and this, if it occurs in vivo, 
may contribute to their ability to mutate and damage normal tissues, and, moreover, 
facilitate tumour growth and invasion (Burdon, 1995). Indeed, it has been suggested that 
persistent oxidative stress in tumour cells could partly explain some important 
characteristics of cancer. A wide variety of normal and malignant cell types generate and 
release superoxide or hydrogen peroxide in vitro either in response to specific cytokine and 
growth factor stimulus or constitutively in the case of tumour cells (Szatrowski at al., 1991). 
Tumors of the nervous system are among the most common and pharmacologically 
intractable neoplastic disorders. Malignant peripheral nervous system tumors include 
neuroblastoma, the most common extracranial solid tumor. Because of the frequency with 
which neuroblastoma is metastatic or otherwise surgically incurable at the time of diagnosis, 
treatment of this tumor often involves chemotherapy. Malignant gliomas comprise the 
majority of primary brain tumors. (Louis et al., 2002). Of these, glioblastoma multiforme 
(GBM) is the most common and has the poorest prognosis. It is therefore apparent that a 
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more complete understanding of malignant gliomas and the pathophysiologic mechanisms 
responsible for tumor growth, invasion, and resistance to therapy is needed. Meningiomas 






Fig. 1. Oxidative stress balance 
2. Oxidative stress and neuronal redox countenance in the brain 
Redox balance in neural tissue has an important role in the pathophysiology of 
neurotoxicity from free radical generation, but also in the pathophysiology of neurotoxicity 
from free radical generation. The concept of redox status includes both physiological and 
pathological effects of redox phenomena. ROS are particularly active in the brain and 
neuronal tissue and aggressive to glial cells and neurons. In-built endogenous antioxidant 
system plays its decisive role in prevention of any loss due to free radicals. However, 
imbalanced defense mechanism of antioxidants, overproduction or incorporation of free 
radicals from environment to living system leads to serious penalty and therefore to 
neuronal death (Halliwell, 2001). The brain has high content of peroxidizable unsaturated 
fatty acids, high oxygen consumption per unit weight, high content of iron which is a key in 
lipid peroxidation and a shortage of antioxidant defense systems (Floyd, 1999) so is more 
susceptible to oxidative stress compared to other tissues and is unique as a target organ for 
metastatic growth being surrounded by the blood-brain barrier.  The generation of ROS, or 
free radicals, can exceed the scavenging ability of endogenous antioxidants, resulting in a 
shift of the redox state of the brain to the oxidative state.  
The concentrations of free heavy metals are also tightly controlled in the nervous system by 
transport proteins such as ferritin (Sies, 1993), thus limiting the non-enzymatic catalysis of 
hydroxyl radical formation. The nervous system contains some antioxidant enzymes; 
including Cu/Zn- and Mn dependent superoxide dismutase (SOD), and glutathione 
peroxidase (GPx) which are expressed in higher quantities than catalase (Shivakumar et al., 
1991; Hussain et al., 1995). This spectrum of enzymatic defences suggests that the brain may 
efficiently metabolize superoxide but may have difficulties in eliminating the hydrogen 
peroxide produced by the reaction. The accumulation of hydrogen peroxide is of major 
concern since the brain contains large quantities of iron and copper (Moos, 1995), which may 
catalyse the formation of the hydroxyl radical and induce lipid peroxidation (Oubidar et al., 
1996)(Fig.1). Exogenous antioxidants are nowadays considered a promising therapeutic 
approach since they could play an important role in preventing and/or minimizing 
neuronal oxidative damage (Halliwell, 2001; Uttara et al., 2009). 
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Fig. 2. Reactions of oxygen and nitrogen species 
3. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are products of normal 
cellular metabolism. The interest in the role of oxygen-free radicals, more generally known 
as ROS and of RNS in experimental and clinical medicine is consequential (Halliwell, 1999). 
ROS/RNS are known to play a dual role since they can be either harmful or beneficial 
(Valko et al., 2004). Utile effects of ROS are having physiological roles in cellular responses 
to noxa and in the function of a number of cellular signalling systems. The harmful effects of 
ROS are balanced by the antioxidant action of nonenzymatic antioxidants in addition to 
antioxidant enzymes (Halliwell, 1996). ROS/RNS are known to act as secondary messengers 
controlling various normal physiological functions of the organism. In addition, ROS and 
RNS participate in various redox-regulatory mechanisms of cells in order to protect cells 
against oxidative stress and maintenance of cellular redox homeostasis. The cumulative 
production of ROS through either endogenous or exogenous insults is common for many 
types of cancer cell that are linked with altered redox regulation of cellular signaling 
pathways.  ROS are not only toxicants to the cell, but also second messengers in intracellular 
signal transduction, and control the action of several signaling pathways. RNS include a 
series of metabolites which are nitric oxide, nitrite, peroxynitrite with functional implication 
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mainly in vascular stability. Overproduction of reactive nitrogen species is called nitrosative 
stress (Klatt & Lamas, 2000).  This may occur when the generation of reactive nitrogen 
species in a system exceeds the system’s ability to neutralise and eliminate them. Nitrosative 
stress may lead to nitrosylation reactions that can alter the structure of proteins and so 
inhibit their normal function and there has been much interest in the roles nitric oxide may 
play in the pathogenesis of GBM. When ROS/RNS levels exceed a certain threshold, 
deleterious effects are apparent and became dangerous for cell integrity  (Panayiotidis et al., 
1999; Barbouti et al., 2002). Oxidative stress can be defined as a deterioration of redox 
signaling and control (Jones, 2006). Overproduction of reactive oxygen species (ROS) and 
reactive nitrogen species (RNS), a decreased antioxidant defense system, or both typically 
results in significant protein oxidation (Hensley et al., 1995; Stadtman & Berlett, 1997), lipid 
peroxidation (Markesbery & Lovell, 1998; Butterfield & Lauderback, 2002), and DNA/RNA 
oxidation (Butterfield et al., 2001). Increased formation of ROS and RNS in the cells can 
contribute to the process of carcinogenesis through either direct genotoxic effects or indirect 
via modification of signaling pathways that lead to altered expression of numerous genes. 
Modulations of cell signaling pathways can activate transcriptional factors, like AP-1, NF-jB, 
HIF-1, and p53 among others (Arrigo, 1999; Bensaad, 2005). These transcriptional factors 
control the expression of genes the protein products of which participate in complex signal 
transduction pathways that can lead to cell transformation.The effect of reactive oxygen and 
nitrogen species is balanced by the antioxidant action of nonenzymatic antioxidants, as well 
as by antioxidant enzymes. Such antioxidant defences are extremely important as they 
represent the direct removal of free radicals, thus providing maximal protection for 
biological sites. As key mediators of cellular oxidative stress and redox state, ROS and RNS 
also provide plausible platforms for drug design. In fact, the efficacy of a number of 
established anticancer drugs.   
4. Redox status and apoptosis 
The intracellular redox state which is directly related to the production of intracellular 
reactive oxygen species in cancer cells has also been indicated to control the aggressiveness 
of cancer cells. Cancer development represents a multistage process in which at least three 
distinct stages which are; initiation, promotion and progression are involved (Klaunig, 2004) 
and is characterized with increased cell growth and/or decreased capacity for apoptosis. 
Apoptosis is potentially a protective mechanism against both exogenous carcinogens and 
inflammatory states and is regulated in part by the cellular redox state. Since apoptosis is 
caused by elevated levels of free radicals, decreased concentrations of free radicals due to 
the excessive administration of antioxidants might actually stimulate survival of damaged 
cells and proliferation into neoplastic state and thus rather promote process of 
carcinogenesis than interrupt it. Mitochondrial driven apoptosis is most interesting when 
ROS mediated mechanisms are being considered. Typical features in apoptosis include 
permeabilization of the mitochondrial membrane in a process associated with ROS 
generation. Some of the physiological effects of free radicals may be mediated through their 
influuence on redox sensitive transcription factors (Suzuki et al., 1997) and consequently 
modulation of gene expression (Cimino et al., 1997). Although care should be taken before 
concluding that free radicals are intracellular second messengers, there is growing 
agreement that they act as modulators of cell signaling and messenger systems. Therefore, it 
seems that the cellular redox status, defined as the balance between intracellular oxidants 
and antioxidants, is regulated so as to lie within an optimal range for cell survival. The 
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importance of cellular antioxidant capacity as the result of a complex cell program involves 
enhanced motility and a profound change in energy metabolism so avoiding oxidative 
damage and escaping excess ROS in the primary tumor site in cancer cells explain why 
redox signaling pathways are important. 
5. Antioxidant defence 
Cells have numerous protective mechanisms that maintain the concentrations of ROS   
within a range compatible with survival. The most efficient enzymatic antioxidants involve 
superoxide dismutase, catalase and glutathione peroxidase (Mates et al., 1999). Non 
enzymatic antioxidants involve vitamin C, vitamin E, carotenoids, thiol antioxidants 
(glutathione, thioredoxin and lipoic acid), natural flavonoids, melatonin and other 
compounds (McCall & Frei, 1999). Some antioxidants act in a hydrophilic environment, 
others in a hydrophobic environment, and some act in both environments of the cell.  
Glutathione (GSH), a thiol-containing tripeptide, is a major antioxidant and a cofactor of 
glutathione peroxidases (Meister, 1995); it is present in large quantities in the developing 
nervous system It has been hypothesized that some trophic factors may upregulate neuronal 
antioxidant capacities (Mattson and Furukawa, 1996). If neuronal death involves an 
imbalance of the redox status towards oxidation, antioxidants should be protective.  
GSH is a major intracellular antioxidant present ubiquitously in the brain in millimolar 
amounts.  GSH detoxifies intracellular H2O2 to H2O and O2 via oxidation to glutathione 
disulfide (GSSG) by the enzyme GPx. GSSG is recycled to GSH via glutathione reductase 
(GR). The GSH/GSSG ratio is critical to maintaining the intracellular redox balance (Smith 
et al., 1996). A decrease in total GSH levels, or an imbalance in the ratio of reduced to 
oxidized GSH may cause oxidative stress (Stadtman & Berlett, 1997) and lipid peroxidation 
(Markesbery & Lovell, 1998). So, the brain is heavily dependent on GSH as a primary 
endogenous neuroprotectant. It has been reported that elevation of intracellular GSH in 
tumour cells is associated with mitogenic stimulation (Shaw & Chou, 1986), that GSH 
controls the onset of tumour-cell proliferation by regulating protein kinase C activity and 
intracellular pH (Terradez et al., 1993). GSH and its dependent enzymes work in concert 
with other antioxidants and antioxidant enzymes to protect cells against reactive oxygen 
intermediates (Sies, 1986). So, it can be said that reduced GSH plays a role in the rescue of 
cells from apoptosis. GPx and GR decrease and protein oxidation increases in patients with 
glioblastoma multiforme and transitional meningioma and clear different oxidative status 
was found in the two kinds of tumors which represent specially one of the most malignant 
and most benign tumors respectively (Tanriverdi et al., 2007) and it was shown that there is 
a complex relationship between pro- and anti-apoptotic molecules in glioblastoma 
multiforme pathogenesis, thus targeting multiple pathways with advanced 
chemotherapeutic agents or radiotheraupetic regimens following total resections might be 
helpful in patients with glioblastoma multiforme (Atukeren et al., 2010). So the development 
of chemopreventive strategies would be desirably based on an association between a 
particular beneficial effect and a redox condition, as for example, with antioxidant 
protection against oxidative stress.  
6. Mitochondrial redox status 
One of the important sources for ROS generation is the mitochondria where some of the 
oxygen  is reduced by single steps of one electron reduction, thus releasing superoxide 
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radical and other ROS (Giorgio et al., 2007). However, it is difficult to detect the occurrence 
of the superoxide radical in intact mitochondria, most probably in consequence of the 
presence of high SOD activity therein. Mitochondria have long been known to generate 
significant quantities of hydrogen peroxide as mitochondrial generation of superoxide to 
that of hydrogen peroxide is known. Since mitochondria are the major site of free radical 
generation, they are highly enriched with antioxidants including GSH and enzymes, such as 
SOD and GPx, which are present on both sides of their membranes in order to minimise 
oxidative stress in the organelle (Cadenas & Davies, 2000).  Superoxide radicals are 
efficiently detoxified initially to hydrogen peroxide and then to water by Cu/ZnSOD and 
MnSOD. The redox components of the cell consists of interlinked mitochondrial redox 
indicators: glutathione (GSH/GSSG), thioredoxin (Trx/TrxR), glutaredoxin (Grx), 
peroxiredoxins (Prx), systems dependent solely on steady flux of NADPH generated 
through reduction of  NADP+ by NADH by the energetic component of mitochondria 
(Figure 3). Trx/TrxR system reverses protein disulfide linkages that occur in thiols of 
oxidized cysteine residues (Holmgren, 1985). Upregulation in the activity of the Trx/TrxR 
system seen in many tumors is thought to be a result of increased ROS production 
associated with oncogenic transformation and correlates with resistance to apoptosis and 
tumor cell proliferation (Baker et al., 1997; Lincoln et al., 2003). Disruption of the cellular 
redox state via inhibition of TrxR, either in the cytosol or the mitochondria has been shown 
to increase the ratio of oxidized/reduced Trx, increase ROS, modulate cell signaling, 
sensitize cancer cell lines to chemotherapeutic agents, and induce cell cycle arrest, 
senescence and apoptosis of cancer cells (Urig &vBecker, 2006; Mukherjee & Martin, 2008) 
so decrease in mitochondrial bioenergetic capacity and altered redox status should be  
 
 
Fig. 3. Redox reactions  
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viewed as a concerted process. Prx are a family of proteins that function in antioxidant 
defense and in redox signaling cascades by reaction with peroxides. During their catalytic 
cycle, oxidized species of Prx are reduced and reactivated by thioredoxin or glutathione 
(Immenschuh & Baumgart-Vogt, 2005; Winterbourn & Hampton, 2008) and GSH is 
important for a wide range of cellular redox active proteins and pathways, including 
glutaredoxin (Grx), glutathione S-transferase (GST), glutathione peroxidase (GPx) and more 
(Meister & Anderson, 1983; Go et al., 2009). 
7. Prospects of antioxidant therapy  
Several antioxidant defense mechanisms have evolved to protect cell components from the 
harmful effects of ROS and RNS. As is known two major groups of endogenous antioxidants 
are low molecular weight antioxidant compounds such as vitamin C and vitamin E, lipoic 
acid and ubiquinones and antioxidant enzymes (Gilgun-Sherki et al., 2001). Antioxidant 
enzymes activity and concentration of nonenzymatic antioxidants in human brain tumours 
were evaluated and significant increases in all enzyme activities and decreases in GSH and 
ascorbate levels were observed in brain tumors (Dudek et al., 2004) and consistent 
differences in the levels of antioxidants in different types of brain tumors were emphasized 
in different studies (Hanimoglu et al., 2007; Tanriverdi et al., 2007; Tuzgen et al., 2007; 
Zengin et al., 2009). The relationship between oxidative gene polymorphism and the risk of 
brain tumors is investigated and it was seen that; the increased risk of glioma and 
meningioma type brain tumors is related with variants in some antioxidant enzyme genes 
(Rajaraman et al., 2008) and in a study, tissue expression of MnSOD is suggested to be a 
prognostic marker for glioblastoma (Park et al., 2009). The importance of daily intake of 
antioxidants among people with malignant glioma was shown in various studies (Il'yasova 
et al., 2009; DeLorenze et al., 2010). Recently, exogenous antioxidants are considered a 
promising therapeutic approach in preventing or minimizing neuronal oxidative damage 
(Halliwell, 2001; Uttara et al., 2009). Recent interest has been focused on dietary phenolic 
antioxidants, such as carotenoids, cinnamic acids and flavonoids, as potentially useful 
agents (Fresco et al., 2006; Uttara et al., 2009). In a study, the effects of flavonoids which are 
natural polyphenolic antioxidant compounds in brain development, neuroprotection and 
glial tumor formation are discussed and suggested to develop new therapeutic approaches 
(Nones et al.; 2010). Curcumin as a polyphenol gets attention in blocking brain tumor 
formation in a study. The chemopreventive and anticarcinogenic action of curcumin is 
shown and suggested as this might be due to its ability to inhibit proteins that initiate 
protective signals (Sudarshana et al., 2009). Also, Gynostemma pentaphyllum extract 
selectively shifted H2O2 concentration in glioma tumor cells to toxic levels due to increased 
SOD activity so can be suggested for cancer therapy (Schild et al., 2010) and the apoptotic 
effect of γ-Mangostin in Garcinia mangostana fruit was investigated and it was suggested as 
a potential in developing an anti brain tumor agent (Chang et al., 2010). In another study, 
the potential therapeutic effect of resveratrol being a dietary phytochemical antioxidant, is 
investigated in glioma type brain tumors (Gangliano et al., 2010). Also another study implies 
the importance of using nutritional antioxidants such as lycopene for their potential 
therapeutic benefit in the adjuvant management of high-grade gliomas (Puri et al., 2010). So 
antioxidants are incontestably implicated in brain cancer treatment and they may protect 
against side effects from conventional therapies, as well as enhance chemotherapy and 
support anticancer activities. Obviously, antioxidants must be chosen based on their ability 
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to treat a particular redox event or they must act contextually and evolve with the redox 
conditions to restore balance. 
3. Conclusion  
Various studies showed that not only oxidants but the redox status as a whole modulates 
mechanisms regulating neuronal fate. The deleterious effects of high concentrations of 
antioxidants and the protective actions of sublethal oxidative challenges suggest that 
neuronal survival depends on the maintenance of an adequate redox status between the two 
extremes of oxidative and reductive stress, respectively. In addition to its widespread 
consequences for our understanding of fundamental aspects of neuronal death, the concept 
of neuronal redox status as opposed to oxidative stress may have clinical implications. 
Neuronal survival thus seems to be associated with an optimal redox status; an imbalance 
towards oxidation leads to oxidative stress, whereas high doses of antioxidants may induce 
a reductive stress. Maintenance of intracellular redox state is critical to cellular homeostasis 
therefore tumor selectivity in targeting at the cellular and enzymatic levels are of great 
interest to the rational design of treating compounds. Targeting the mitochondrial apoptotic 
regulatory machinery is also a promising anticancer approach and in many studies thiol 
redox platforms were used to discover and develop drugs. Strategies for redox balance 
analysis rely on different  assumption and this approach gives a dynamic idea of  what is the 
general oxidative status in a given condition and evaluation of redox potential of molecules 
gives idea of what really happened in a period that is a function of half life of a given 
molecule so this maybe utilized in parallel to gain a more representative picture of a clinical 
conditioning evolution. Hence, chemotherapeutic outcomes are not compromised, 
administration of antioxidants capable of maintaining the antioxidant defense system in 
brain may protect cancer patients from the apparent cognitive rigors of chemotherapy and 
these redox manipulating compounds could be used in conjunction with existing treatments 
to beneficial effect. So, it can be said that, as a preliminary approach, to determine optimal 
doses of antioxidants in order to design treatment protocols respecting the redox 
homeostasis would be useful. 
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